What development phase is Allyltrenbolone in?

Allyltrenbolone is FDA-approved (marketed).

What is the generic name of Allyltrenbolone?

ALTRENOGEST is the generic (nonproprietary) name of Allyltrenbolone.

Last reviewed 2026-04-20 · How we verify

Allyltrenbolone (ALTRENOGEST)

FDA-approved active Small molecule Quality 6/100

ALTRENOGEST, an allyltrenbolone-based drug, is currently on the market with a key composition patent expiring in 2028. The drug's mechanism of interacting with specific receptors in the body provides a unique therapeutic approach. The primary risk is the lack of clear revenue data and key trial results, which may impact investor confidence and market positioning.

At a glance

Generic name	ALTRENOGEST
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.